Lilly acquires CrossBridge Bio
Lilly also has plans to buy Texas-based startup CrossBridge Bio, which is creating ADCs.
Company lists
Oncology, genomics, platforms and tools, medical devices, startups and more: the companies building life sciences in Texas, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 1,256 life sciences companies in Texas, last 24 months: 50 funding rounds · 36 M&A deals · 22 Contracts · 4 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: May 2026.
Lilly also has plans to buy Texas-based startup CrossBridge Bio, which is creating ADCs.
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has announced a private placement expected to generate approximately $22.5 million in gross proceeds, according to a press release.
Later in March, AllianzGI signed an agreement to acquire an indirect stake in Amprion, Germany's second-largest electricity transmission system operator.
Lilly is acquiring CrossBridge Bio (~$300M reported) to bolster oncology capabilities — diversifies growth beyond obesity/diabetes.
Lantern Pharma Inc. has announced the commercial launch of withZeta.ai, its multi-agentic AI co-scientist platform designed specifically for rare cancer drug discovery.
Dallas-based Verily has raised a new $300 million investment round led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz, and other…
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the launch of its CEO Corner, a new platform featuring Walter Klemp, Chief Executive Officer.
CEC Liquid Telecom announced that it had acquired Zambian ISP, Realtime, the country’s second largest ISP.
Coya Therapeutics has raised about $11.1 million in a private investment round to support commercial-readiness efforts for COYA 302, its experimental immune-modulating therapy being…
AIGH Capital Management LLC purchased a new stake in Castle Biosciences, Inc. in the 3rd quarter valued at approximately $16,105,000.
Traditional expanded polystyrene (EPS) is on the run, being replaced by all‑paper containers (designated as “curbside recyclable”) from Sonoco ThermoSafe (its EOS brand) and Truetemp…
Sonoco ThermoSafe, a temperature assurance packaging company, and Turkish Airlines, have signed a master lease agreement to offer Sonoco’s Pegasus unit load device (ULD)…
Cypher Metaverse Inc. (CSE:CODE.X) has announced a definitive agreement to acquire Noninvasix, Inc., creating a "Reverse Takeover" under Canadian Securities Exchange policies.
Noninvasix intends to complete an equity financing of units in its capital for minimum gross proceeds of US$3,000,000
"Noninvasix intends to complete an equity financing of units in its capital ('Noninvasix Units') for minimum gross proceeds of US$3,000,000 (the 'Noninvasix Private Placement')."
"Cypher Metaverse Inc. (CSE:CODE.X) ('Cypher' or the 'Company') is pleased to announce that it has entered into an arms-length definitive agreement dated December 12, 2025 (the…
Curative – $150.0M
Salarius Pharmaceuticals, Inc. (NasdaqCM:SLRX) completed the acquisition of Decoy Therapeutics Inc. on November 12, 2025.
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the closing of its previously announced underwritten public…
Savara sold to certain investors that so chose, pre-funded warrants to purchase 7,142,857 shares of common stock at a price of $4.199 per pre-funded warrant. The aggregate gross proceeds…
On October 28, 2025, Genprex, Inc. announced a securities purchase agreement for a registered direct offering of 377,780 shares of common stock at $9.00 per share, expected to close on…
Dallas-based precision health AI company Verily has launched a new consumer health app, Verily Me.
Actuate Therapeutics, Inc. (NASDAQ: ACTU) ("Actuate" or the "Company") ... the closing of its $17.25 million underwritten public offering of 2,464,286 shares of its common stock,…
This operation provides for Apollo to acquire a 25.1 % stake in Amprion from RWE for EUR 3.2 billion.
StatLab Medical Products has completed the acquisitions of Germany-based Histoserve GmbH and Diapath France SAS, strengthening its direct sales presence in Europe’s top four pathology…
In parallel, StatLab acquired the remaining stake in Diapath France—a joint venture formed in 2023 between Diapath and Jacques Hannaby to serve the direct laboratory market in France.
Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily…
Healthcare AI company Autonomize AI has closed a $28m Series A funding round, bringing its total raised to $32m.
Abeona Therapeutics took second place in the private biotech fundraising standings after it managed to raise $155 million by selling its U.S. Food and Drug Administration (FDA) priority…
May 2025 saw Taysha Gene Therapies bag the biggest public biotech investment of the month, with the company pricing a $200 million public offering. The company is focused on advancing…
Few life sciences companies in Texas publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 926 active companies.

Developer of precision health platforms and solutions using artificial intelligence
Healthcare itUS$2.80bn across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of panomic disease profiling technologies for cancer precision medicine
GenomicsUS$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing drugs and delivery system along with theranostic imaging primarily for CNS disorders
Life sciences platforms and toolsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drug-delivery solution for the treatment of pediatric wart treatment
DermatologyUS$262.71m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Controlled-release minoxidil formulations for hair growth and dermatological therapy
CPC A61K31/506, A61M37/0015, A61K31/122Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a robotic system for endoluminal and single-incision surgery
Professional service robotsUS$232.48m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Robotic surgical system control, instrumentation, and accessories for minimally invasive procedures.
CPC A61B34/30, A61B34/74, A61B34/37Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies to treat glaucoma and other diseases of the eye
OphthalmologyUS$170.50m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of neuromodulation therapy for neurological conditions
NeurologyUS$179.95m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Vagus nerve stimulation integrated with motor and therapeutic rehabilitation devices
CPC A61N1/36067, A61F11/00, A61M21/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of devices to lift the burden of heart failure
Cardiac and vascular disordersUS$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of therapeutics to treat kidney diseases
Metabolic diseasesUS$168.51m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of an immunotherapy platform for oncology and other diseases
GastroenterologyUS$165.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Bispecific immunomodulatory antibodies and TRIM7‑targeted protein therapeutics, including mRNA formats.
CPC C07K14/70503, C07K14/70575, C07K14/705Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of self collecting COVID-19 testing centers listing platform
Infectious diseasesUS$162.35m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic sample collection, nucleic acid purification, and infection profiling technologies.
CPC A61K51/1096, G01N33/6854, C12N15/1006Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a device for organ preservation
Transplant medicineUS$151.67m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Ex vivo organ/tissue perfusion devices for preservation and viability monitoring
CPC A01N1/143, C12N5/542, C01B3/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of T-cell therapies to treat infectious diseases
Life sciences platforms and toolsUS$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a compound that exploits pH as a biomarker to diagnose and treat cancer
OncologyUS$137.97m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
ImmunotherapyUS$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of prescription lenses and solution for problems related to Digital Vision Syndrome
OphthalmologyUS$126.19m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene-based therapies for treating CNS disorders
NeurologyUS$125.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a novel cancer therapy targeting Treg cells
OncologyUS$121.40m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome
Cardiac and vascular disordersUS$114.35m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Percutaneous intravascular blood pumps for mechanical circulatory support and perfusion.
CPC A61M60/139, A61M60/865, F04D3/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunotherapeutics for the treatment of cancer
OncologyUS$110.76m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Platform offering CRM software for pharmacies
Sales force automationUS$106.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of multiple diagnostics platforms for infectious diseases
Infectious diseasesUS$105.29m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Microfluidic single‑cell diagnostic platforms and sample‑handling technologies for cellular phenotyping
CPC B01L3/502784, C12Q1/24, C12Q1/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Speciality Company developing extended release drugs for CNS disorders using proprietary technology platform
NeurologyUS$94.64m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of disinfection robots for multiple healthcare purposes
Hospital equipmentUS$94.39m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Proivder of DNA test kits for dogs that enable dog owners to provide better pet care
GenomicsUS$93.97m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Canine genetic testing platforms for pigmentation and ancestry phenotype prediction
CPC G16B30/10, G16B20/20, G16B10/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of vaccine development and management devices for researchers
Infectious diseasesFocus: Nanomaterial-based conductive inks, transparent electrodes, and optoelectronic coatings
CPC B82Y30/00, C09D11/52, H10K85/215Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule based therapeutics for cancer treatment
OncologyUS$83.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision medicines for pulmonary diseases
PulmonologyUS$82.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Personalized cancer immunotherapy company advancing treatment through Vigil platform
ImmunotherapyUS$80.66m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Nucleic‑acid therapeutics targeting cancer and genetic muscle disorders, including RNAi and neoantigen vaccines.
CPC C12N15/1135, C12N15/1017, C12N15/85Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing microRNA-based oncology therapies for solid and hematologic cancers
Gene therapyUS$77.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for hard-to-treat cancer
OncologyUS$72.23m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for rare respiratory diseases
PulmonologyUS$67.82m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for treating leukemia disease
OncologyUS$65.80m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics and diagnostics for cancer
GenomicsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for multiple indications
DermatologyUS$63.20m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of diagnostic devices for treating cancer
DermatologyUS$61.97m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostics and prognostics for skin cancers and inflammatory skin diseases.
CPC C12Q1/6886, C12Q1/68, G16H50/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies for treating rare and neurodegenerative diseases
NeurologyUS$60.18m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic use of N‑acetyl‑leucine for rare neurodegenerative and lysosomal disorders
CPC A61K31/198, A61P21/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovating medical devices and biotechnology solutions for critical care and research
Cardiac and vascular disordersUS$56.35m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable vena cava filtration and catheter systems for intravascular blood clot management
CPC A61F2/01, A61M25/0097, A61F2/011Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for rare metabolic disorders
Rare diseasesUS$56.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of T-cell therapies for treating cancers
Cell therapyFocus: Bispecific T‑cell engager antibodies targeting Claudin‑18.2, GUCY2C, and GPC3 for cancer immunotherapy.
CPC A61K40/4215, A61K40/11, A61K40/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a clinical trail workflow management software for laboratories
Life sciences techUS$54.97m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Semantic knowledgebases and intelligent object-based data integration platforms with remote access
CPC G06F16/20, G06F16/284, G06F16/27Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of optoacoustic imaging systems for cancer diagnosis
PhotonicsUS$54.07m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Optoacoustic medical imaging systems for lesion characterization and lymph node diagnostics
CPC A61B5/0095, G06T7/0012, A61B8/5292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of cell-separation technology for regenerative medicine
Life sciences platforms and toolsUS$51.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12N5/0653, C12N5/0667, A61K35/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of genomic services for forensic labs
GenomicsUS$48.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Secure storage and privacy-preserving processing of genomic data
CPC G06N3/123, G16B40/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of vacuum ultraviolet absorption spectroscopic instruments
PhotonicsUS$48.34m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: VUV absorption spectroscopy systems and flow cells for high‑sensitivity liquid analysis.
CPC G01N30/78, G01N21/255, G01N30/8693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of blood testing service using microsamples collected from a finger.
Diversified diagnosticsUS$37.70m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Automated blood sample handling and centrifugation for point‑of‑care diagnostics
CPC G01N35/04, B01L3/5021, B01L3/50215Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunotherapeutic cancer treatments targeting HLA‑G antigen
ImmunotherapyUS$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for treating tumors
ImmunotherapyFocus: Targeted hypoxia‑activated prodrugs and STING agonist combos for cancer immunotherapy
CPC A61K31/396, A61K31/675, A61K31/7084Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Oncolytic virus platform for treating malignant glioma.
ImmunotherapyUS$42.96m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Oncolytic adenovirus gene therapies targeting pediatric brain tumors and immune activation
CPC A61K35/761, C12N7/00, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of targeted radiopharmaceuticals for cancer diagnosis and treatment
Imaging diagnosticsFocus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Texas on RadarFind top life sciences companies in Texas across oncology, genomics, medical technology, and therapeutics. Explore life sciences companies in Texas by the science and care areas they serve.
Companies developing cancer diagnostics, therapies, and research tools.

Developer of panomic disease profiling technologies for cancer precision medicine
Genomics
Developer of a compound that exploits pH as a biomarker to diagnose and treat cancer
Oncology
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
Immunotherapy
Developer of a novel cancer therapy targeting Treg cells
Oncology
Developer of small molecule based therapeutics for cancer treatment
OncologyCompanies working with genetic data, testing, and clinical diagnostics.

Developer of panomic disease profiling technologies for cancer precision medicine
Genomics
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
Immunotherapy
Proivder of DNA test kits for dogs that enable dog owners to provide better pet care
Genomics
Developer of therapeutics and diagnostics for cancer
Genomics
Provider of diagnostic devices for treating cancer
DermatologyProviders of laboratory technologies, research platforms, and scientific instruments.

Provider of vacuum ultraviolet absorption spectroscopic instruments
PhotonicsProvider of molecular assays and laboratory building for medical facilities
Life sciences platforms and tools
Developer of IVD and targets cancer cells for therapeutics
Life sciences platforms and tools
Developer of point of care diagnostic technology for automation of Enzyme Immunoassay
Life sciences platforms and tools
Analytical lab instruments
Life sciences platforms and toolsCompanies building devices, implants, and equipment for care and surgery.

Developer of neuromodulation therapy for neurological conditions
Neurology
Developer of devices to lift the burden of heart failure
Cardiac and vascular disorders
Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome
Cardiac and vascular disorders
Innovating medical devices and biotechnology solutions for critical care and research
Cardiac and vascular disorders
Developer of orthopedic medical implants
OrthopedicsRecently founded life sciences companies in Texas.

Developer of CAR-T cell therapies for malignancies
Oncology
AI-based drug discovery tool for researchers
Life sciences tech
Provider of immunotherapeutics for cancer treatment
Neurology
Provider of sales enablement platform to life sciences companies
Life sciences tech
Cloud-based data management tool for providers
Life sciences techLife sciences companies in Texas with hiring activity.

Developer of drug-delivery solution for the treatment of pediatric wart treatment
Dermatology
Developer of neuromodulation therapy for neurological conditions
Neurology
Developer of an immunotherapy platform for oncology and other diseases
GastroenterologyDeveloper of a device for organ preservation
Transplant medicine
Developer of gene-based therapies for treating CNS disorders
NeurologyPublicly listed life sciences companies in Texas.

Developer of panomic disease profiling technologies for cancer precision medicine
Genomics
Developer of drug-delivery solution for the treatment of pediatric wart treatment
Dermatology
Developer of therapies to treat glaucoma and other diseases of the eye
Ophthalmology
Developer of an immunotherapy platform for oncology and other diseases
Gastroenterology
Developer of T cell therapies for the treatment of cancer and chronic infectious diseases
ImmunotherapyThe most-installed Android apps published by life sciences companies headquartered in Texas — 588K installs between them. 24 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Texas compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 1,256 life sciences companies in Texas among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of Texas maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
255 life sciences companies in Texas have recorded equity funding, US$10.89bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
Healthcare itDeveloper of precision health platforms and solutions using artificial intelligence
GenomicsDeveloper of panomic disease profiling technologies for cancer precision medicine
Life sciences platforms and toolsDeveloping drugs and delivery system along with theranostic imaging primarily for CNS disorders
DermatologyDeveloper of drug-delivery solution for the treatment of pediatric wart treatment
Professional service robotsDeveloper of a robotic system for endoluminal and single-incision surgery
OphthalmologyDeveloper of therapies to treat glaucoma and other diseases of the eye
NeurologyDeveloper of neuromodulation therapy for neurological conditions
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
Metabolic diseasesProvider of therapeutics to treat kidney diseases
GastroenterologyDeveloper of an immunotherapy platform for oncology and other diseases
Infectious diseasesProvider of self collecting COVID-19 testing centers listing platform
Developer of a device for organ preservation
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
OncologyDeveloper of a compound that exploits pH as a biomarker to diagnose and treat cancer
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
OphthalmologyProvider of prescription lenses and solution for problems related to Digital Vision Syndrome
US$2.80bn across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$262.71m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Controlled-release minoxidil formulations for hair growth and dermatological therapy
CPC A61K31/506, A61M37/0015, A61K31/122Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$232.48m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Robotic surgical system control, instrumentation, and accessories for minimally invasive procedures.
CPC A61B34/30, A61B34/74, A61B34/37Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$170.50m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$179.95m across 10 disclosed equity rounds
Darker bars = larger roundsFocus: Vagus nerve stimulation integrated with motor and therapeutic rehabilitation devices
CPC A61N1/36067, A61F11/00, A61M21/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$168.51m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$165.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Bispecific immunomodulatory antibodies and TRIM7‑targeted protein therapeutics, including mRNA formats.
CPC C07K14/70503, C07K14/70575, C07K14/705Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$162.35m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic sample collection, nucleic acid purification, and infection profiling technologies.
CPC A61K51/1096, G01N33/6854, C12N15/1006Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$151.67m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Ex vivo organ/tissue perfusion devices for preservation and viability monitoring
CPC A01N1/143, C12N5/542, C01B3/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$137.97m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$126.19m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Texas. 577 of 926 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences platforms and toolsProvider of RNA extraction reagents and products
Founders
Details not available
NeurologySpeciality Company developing extended release drugs for CNS disorders using proprietary technology platform
Infectious diseasesAmarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.
Founders
Details not available
Asset managementDiversified investment management firm
Founders
Details not available
PhotonicsProvider of vacuum ultraviolet absorption spectroscopic instruments
Drug deliveryProvides portfolio of smart syringes and needles to prevent from needle-stick injuries
GenomicsProvider of molecular diagnostic services for the detection of a wide range of diseases
Founders
Details not available
NeurologyDeveloper of gene-based therapies for treating CNS disorders
Life sciences techCloud-based eClinical platform for clinical trial setup and management
Nutraceuticals techInnovative functional ingredient supplier specializing in organic, sustainable, and traceable solutions
NanotechnologyNanotechnology transforming drug delivery with sustained-release implantable devices
Life sciences techProvider of sales enablement platform to life sciences companies
Focus: RNA extraction, preservation, and analysis technologies for research and diagnostic applications.
CPC C12Q1/6806, C12N9/22, C12N15/1003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$94.64m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.34m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: VUV absorption spectroscopy systems and flow cells for high‑sensitivity liquid analysis.
CPC G01N30/78, G01N21/255, G01N30/8693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$125.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.21m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$30.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Texas with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsProvider of multi omics based metabolic signature program and solutions for metabolic health issues
Healthcare itDeveloper of precision health platforms and solutions using artificial intelligence
GenomicsDeveloper of panomic disease profiling technologies for cancer precision medicine
Cardiac and vascular disordersDeveloper of devices to lift the burden of heart failure
Dental disordersDeveloper of an invisible orthodontic treatment system. This system uses a patented biomechanical approach to independently move teeth, resulting in faster treatment times compared to traditional methods. The system is designed for ease of use for both patients and orthodontists, minimizing the need for frequent adjustments and maximizing comfort. The treatment is discreet, as the devices are placed on the back of the teeth.
DermatologyDeveloper of smart devices by using domestic aesthetic technologies
Imaging diagnosticsDeveloper of targeted radiopharmaceuticals for cancer diagnosis and treatment
GenomicsDiagnostic lab providing fast, accurate results for providers and patients
Ent disordersDoctor-recommended ear care solutions for earwax, pain, and itch relief
ImmunotherapyDeveloping immunotherapies to prevent and treat life-threatening diseases
OncologyDeveloper of minimally invasive lung tissue excision tool for lung cancer
3d printingOnline casino and sports betting platform with diverse gaming options
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.80bn across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$179.87m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$21.15m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Orthodontic appliance design and teeth repositioning systems for dental alignment.
CPC A61C7/303, A61C7/22, A61C7/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$25.50m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced cooling and electromagnetic systems for aesthetic skin treatment devices
CPC A61N5/0616, A61B18/02, A61B18/203Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Topical otic formulations for cerumen (earwax) removal and treatment
CPC A61K9/0046Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.04m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced control and sealing systems for minimally invasive thoracic tissue resection.
CPC A61B17/32053, A61B18/082, A61B17/320092Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.44m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Dermatology depigmentation therapies and tissue‑engineered medical device manufacturing
CPC C12N5/0626, A61K35/28, A61K9/7038Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Texas founded in the last four years, newest first.
Online retailer of nutritional supplements, vitamins, and wellness products
Founders
Details not available
Provider of molecular assays and laboratory building for medical facilities
Founders
Details not available
PediatricsDeveloper of medical devices focused on neonatal and premature infant care
Founders
Details not available
OncologyProvider of AI based lymph node malignancy classification solution
Women healthDeveloper of gene therapies targeting metastatic cancer, especially liver metastasis
Life sciences techDeveloper of AI tools for research in cardiology and neurology
Digital transaction managementProvider of standard operating procedures and documentation for biotech companies
Provider of 3D printers, biomaterials, surgical guides, and design services
Founders
Details not available
NeurologyDeveloper of therapeutics for longevity-related diseases
Developer of therapeutics for cancer treatment
Founders
Details not available
ImmunotherapyDeveloper of proteins and monoclonal antibodies for the treatment of infectious diseases
PulmonologyProvider of a biomarker test for early lung cancer detection
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$300k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Electronic transaction processing platforms and payment system automation
CPC G06Q30/0603, G06Q30/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
OrthopedicsDeveloper of reconstructive and regenerative solutions for bone-related conditions
Founders
Details not available
Infectious diseasesDeveloper of therapeutics for infectious disease
DermatologyProvider of diagnostic devices for treating cancer
GenomicsDeveloper of small molecule drugs for diffrent health diseases
Founders
Details not available
NeurologyDeveloper of gene-based therapies for treating CNS disorders
PulmonologyDeveloper of therapeutics for rare respiratory diseases
OncologyProvider of therapeutics for multiple cancer treatments
ImmunotherapyDeveloper of therapeutics for cell therapy and exosome therapy
Life sciences platforms and toolsDeveloper of IVD and targets cancer cells for therapeutics
Vagus nerve stimulation device for epilepsy and treatment resistant depression
Founders
Details not available
OncologyDeveloper of treatments for primary and metastatic cancers in the brain and central nervous system
GenomicsDeveloper of panomic disease profiling technologies for cancer precision medicine
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Powder-based drug delivery devices for inhalation or topical administration
CPC A61M35/003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$61.97m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostics and prognostics for skin cancers and inflammatory skin diseases.
CPC C12Q1/6886, C12Q1/68, G16H50/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in chemistry & materials
CPC C07D487/04, C07D233/64, C07D401/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$125.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$67.82m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$20.44m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.05m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Automated flow cytometry with AI for lung health monitoring and early cancer detection
CPC G01N33/575, G01N33/5752, G01N33/5091Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Implantable vagus nerve stimulation devices for cardiac, sleep‑apnea, and epilepsy therapy
CPC A61N1/36139, A61N1/36114, A61N1/36082Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Texas. Open a company to see what it sells, who runs it and how far it has come.
144 life sciences companies in Texas work in oncology. Shown: the best-documented.
GenomicsDeveloper of panomic disease profiling technologies for cancer precision medicine
DermatologyProvider of diagnostic devices for treating cancer
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
Cell therapyDeveloper of T-cell therapies for treating cancers
OncologyProton radiotherapy system
PhotonicsProvider of optoacoustic imaging systems for cancer diagnosis
ImmunotherapyDeveloper of small molecules-based therapeutic solutions for the treatment of cancer
GenomicsDeveloper of therapeutics to treat cancer at molecular level
Gene therapyDeveloping microRNA-based oncology therapies for solid and hematologic cancers
Imaging diagnosticsDeveloper of targeted radiopharmaceuticals for cancer diagnosis and treatment
ImmunotherapyDeveloper of immunotherapeutic cancer treatments targeting HLA‑G antigen
OncologyProvider of a medical device for detecting and monitoring cancer
US$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$61.97m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostics and prognostics for skin cancers and inflammatory skin diseases.
CPC C12Q1/6886, C12Q1/68, G16H50/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Bispecific T‑cell engager antibodies targeting Claudin‑18.2, GUCY2C, and GPC3 for cancer immunotherapy.
CPC A61K40/4215, A61K40/11, A61K40/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$21.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.07m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Optoacoustic medical imaging systems for lesion characterization and lymph node diagnostics
CPC A61B5/0095, G06T7/0012, A61B8/5292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Cancer immunotherapy and nanoparticle-based therapeutics for solid and hematologic malignancies
CPC C07K14/4726, C12N5/064, C12N15/86Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.11m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted gene‑therapy vectors and nucleic‑acid treatments for specific cancers
CPC C07K14/4703, A61P35/00, C07K14/525Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$77.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Automated production of lead‑212 radionuclide for targeted alpha‑particle cancer therapy
CPC A61K51/0497, A61P35/00, C07H17/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$44.49m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered CAR‑T cell immunotherapy targeting HLA‑G antigen
CPC C07K14/7051Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.30m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
118 life sciences companies in Texas work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsProvider of RNA extraction reagents and products
Founders
Details not available
Life sciences platforms and toolsDeveloper of T-cell therapies to treat infectious diseases
PhotonicsProvider of vacuum ultraviolet absorption spectroscopic instruments
Life sciences platforms and toolsProvides services to store adult stem cells for medical treatments
Life sciences platforms and toolsDeveloper of cell-separation technology for regenerative medicine
Life sciences platforms and toolsDeveloper of IVD and targets cancer cells for therapeutics
Life sciences platforms and toolsDeveloper of point of care diagnostic technology for automation of Enzyme Immunoassay
Life sciences platforms and toolsAptamer discovery and development services for diagnostics, therapeutics, and research
Life sciences platforms and toolsDeveloper of protein-based biomaterial platform for energy, environment, and medicine
Life sciences platforms and toolsCell culture technology company advancing regenerative medicine and drug discovery
3d printingOnline casino and sports betting platform with diverse gaming options
Advanced materialsProvider of ornithological bone void filler bio-materials
Focus: RNA extraction, preservation, and analysis technologies for research and diagnostic applications.
CPC C12Q1/6806, C12N9/22, C12N15/1003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$151.25m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy
CPC C12M23/24, A61P31/20, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.34m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: VUV absorption spectroscopy systems and flow cells for high‑sensitivity liquid analysis.
CPC G01N30/78, G01N21/255, G01N30/8693Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$51.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12N5/0653, C12N5/0667, A61K35/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.05m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Automated flow cytometry with AI for lung health monitoring and early cancer detection
CPC G01N33/575, G01N33/5752, G01N33/5091Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Point‑of‑care microfluidic diagnostic devices using discontinuous fluidic systems
CPC G01N33/54333Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.06m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Designing functional ligands/aptamers for diverse molecular targets, including proteins and small molecules.
CPC C12N15/115, C12Q1/6811, C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.54m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Stem cell-derived amniotic ECM for cardiac tissue engineering and cardiotoxicity screening
CPC C12N5/0657, A61K35/28, C12N5/0605Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.44m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Dermatology depigmentation therapies and tissue‑engineered medical device manufacturing
CPC C12N5/0626, A61K35/28, A61K9/7038Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.84m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Orthopedic bone fixation and spinal/pelvic stabilization implants with cement delivery systems
CPC A61B17/7055, A61B17/84, A61F2/4455Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
108 life sciences companies in Texas work in genomics. Shown: the best-documented.
GenomicsProvider of multi omics based metabolic signature program and solutions for metabolic health issues
GenomicsDeveloper of panomic disease profiling technologies for cancer precision medicine
Life sciences platforms and toolsProvider of RNA extraction reagents and products
Founders
Details not available
GenomicsProivder of DNA test kits for dogs that enable dog owners to provide better pet care
Founders
Details not available
ImmunotherapyDeveloper of T cell therapies for the treatment of cancer and chronic infectious diseases
GenomicsDeveloper of therapeutics to treat cancer at molecular level
GenomicsDeveloping drug and companion diagnostics for multi-drug resistant cancers
Founders
Details not available
GenomicsProvider of genomic services for forensic labs
GenomicsDiagnostic lab providing fast, accurate results for providers and patients
Women healthDeveloper of a non-invasive pre-natal diagnostic test
GenomicsCancer care management platform
GenomicsProvider of clinical intelligence platform for precision oncology and immunotherapy
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.23bn across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: RNA extraction, preservation, and analysis technologies for research and diagnostic applications.
CPC C12Q1/6806, C12N9/22, C12N15/1003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$93.97m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Canine genetic testing platforms for pigmentation and ancestry phenotype prediction
CPC G16B30/10, G16B20/20, G16B10/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$137.53m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.11m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted gene‑therapy vectors and nucleic‑acid treatments for specific cancers
CPC C07K14/4703, A61P35/00, C07K14/525Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.12m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Secure storage and privacy-preserving processing of genomic data
CPC G06N3/123, G16B40/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.24m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.38m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.69m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Personalized medicine data analysis and recommendation platform
CPC G06F19/3443, G06F19/3456Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
97 life sciences companies in Texas work in life sciences tech. Shown: the best-documented.
GenomicsProvider of multi omics based metabolic signature program and solutions for metabolic health issues
Healthcare itDeveloper of precision health platforms and solutions using artificial intelligence
Sales force automationPlatform offering CRM software for pharmacies
Life sciences techProvider of a clinical trail workflow management software for laboratories
Life sciences techCloud-based data management tool for providers
Life sciences techProvider of a platform for process management software for pharma manufacturing
Life sciences techDeveloper of a clinical platform designed to accelerate clinical development
Life sciences techAI-based drug discovery tool for researchers
Life sciences techProvider of sales enablement platform to life sciences companies
Life sciences techProvider of decentralised clinical research and trial solution for patients
Founders
Details not available
Healthcare itProvider of an AI-based decision-making tool for healthcare professionals
Life sciences techComputational drug design platform for neurological conditions
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.80bn across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$106.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.97m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Semantic knowledgebases and intelligent object-based data integration platforms with remote access
CPC G06F16/20, G06F16/284, G06F16/27Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$30.61m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.41m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Clinical trial software: UI, code generation, and specimen management tools
CPC G16H10/20, G06F16/9027, G16H70/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$32.02m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$30.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.83m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
307 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.